AIM

AIM ImmunoTech
AIM

Overview Fund Trends Analyst Outlook Journalist POV

16 hedge funds and large institutions have $434K invested in AIM ImmunoTech in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
16
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$28K
2
+$16K
3
+$13.5K
4
UBS Group
UBS Group
Switzerland
+$3K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.5K

Top Sellers

1
-$65.5K
2
-$9K
3
-$1.75K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$160K
2
$102K
3
$28K
4
$25K
5
$21K
6
$18K
7
$16K
8
$14K
9
$11K
10
$9K
11
$7K
12
$7K
13
$5K
14
$5K
15
$3K
16
$3K